Literature DB >> 2454896

Value correlation of alpha-fetoprotein and human chorionic gonadotropin with the results of lymphadenectomy in non-seminomatous testicular tumours.

J Kausitz1, S Hupka, D Ondrus, J Michalko.   

Abstract

In a group of 131 patients with nonseminomatous testicular tumours, the authors correlated the postorchiectomic levels of alpha-fetoprotein and human chorionic gonadotropin with the results of lymphadenectomy. They found 90.5% correlation of negative and 74% of positive levels of tumour markers with results of lymphadenectomy. In spite of 9.5% false positive and 25.7% false negative results the authors concluded that determination of alpha-fetoprotein and human chorionic gonadotropin is an important contribution to the detection of residual nonseminomatous tumour tissues after orchiectomy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454896     DOI: 10.1007/bf02550664

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  5 in total

1.  Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas.

Authors:  G D Braunstein; K R McIntire; T A Waldmann
Journal:  Cancer       Date:  1973-05       Impact factor: 6.860

2.  Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.

Authors:  P H Lange; K R McIntire; T A Waldmann; T R Hakala; E E Fraley
Journal:  N Engl J Med       Date:  1976-11-25       Impact factor: 91.245

3.  Serum alpha-foetoprotein as a marker for endodermal sinus tumour (yolk sac tumour) or a vitelline component of "teratocarcinoma".

Authors:  B Norgaard-Pedersen; R Albrechtsen; G Teilum
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-11

4.  Letter: Syncytiotrophoblasts in malignant testicular tumours.

Authors:  E Heyderman; A M Neville
Journal:  Lancet       Date:  1976-07-10       Impact factor: 79.321

5.  Correlation of serum tumor markers and lymphangiography with degrees of nodal involvement in surgical stage II testis cancer.

Authors:  D Vugrin; W F Whitmore; J Nisselbaum; R C Watson
Journal:  J Urol       Date:  1982-04       Impact factor: 7.450

  5 in total
  1 in total

1.  Three cycles of etoposide and cisplatin chemotherapy in clinical stage IS nonseminomatous testicular cancer.

Authors:  Zaza Mezvrishvili; Laurent Managadze
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.